BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7591838)

  • 21. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
    Little MP
    Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors.
    Cologne JB; Tokuoka S; Beebe GW; Fukuhara T; Mabuchi K
    Radiat Res; 1999 Oct; 152(4):364-73. PubMed ID: 10477913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of cancer among children exposed to atomic bomb radiation in utero: a review.
    Kato H; Yoshimoto Y; Schull WJ
    IARC Sci Publ; 1989; (96):365-74. PubMed ID: 2680953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992.
    Delongchamp RR; Mabuchi K; Yoshimoto Y; Preston DL
    Radiat Res; 1997 Mar; 147(3):385-95. PubMed ID: 9052687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid tumors in atomic bomb survivors in Hiroshima: first report of surgical cases, 1956-1988.
    Takeichi N; Dohi K; Ito H; Hara H; Usui T; Yokoro K
    Hiroshima J Med Sci; 1991 Jun; 40(2):75-7. PubMed ID: 1917558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study.
    Yamada M; Naito K; Kasagi F; Masunari N; Suzuki G
    Int J Radiat Biol; 2005 Nov; 81(11):821-6. PubMed ID: 16484151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Health effects of atomic bomb radiation].
    Shigematsu I
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis.
    Kai M; Luebeck EG; Moolgavkar SH
    Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
    Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.
    Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S
    Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid cancer mortality risk among a cohort of Hiroshima early entrants after the atomic bombing, 1970-2010: implications regarding health effects of residual radiation.
    Otani K; Ohtaki M; Yasuda H
    J Radiat Res; 2022 Aug; 63(Supplement_1):i45-i53. PubMed ID: 35968990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection, follow-up, and analysis in the Atomic Bomb Casualty Commission Study.
    Jablon S
    Natl Cancer Inst Monogr; 1985 May; 67():53-8. PubMed ID: 4047151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint effects of radiation and smoking on lung cancer risk among Atomic bomb survivors.
    Pierce DA; Sharp GB; Mabuchi K
    Radiat Res; 2005 Jun; 163(6):694-5. PubMed ID: 16044494
    [No Abstract]   [Full Text] [Related]  

  • 39. Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors.
    Lagarde F
    Health Phys; 2006 Dec; 91(6):608-18. PubMed ID: 17099404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperparathyroidism among atomic bomb survivors in Hiroshima.
    Fujiwara S; Sposto R; Ezaki H; Akiba S; Neriishi K; Kodama K; Hosoda Y; Shimaoka K
    Radiat Res; 1992 Jun; 130(3):372-8. PubMed ID: 1594765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.